25 May 2013
Keywords: switzerland, first, approve, novartis, tasigna, become, nation
Article | 30 July 2007
Switzerland has become the first nation to approve Novartis' Tasigna (nilotinib) for patients with chronic myeloid leukemia who are resistant
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 July 2007
24 May 2013
© 2013 thepharmaletter.com